Skip to content
Clinical Trials – home

Non-small cell lung cancer Life with Disease

141 / 326 trials open to patients27 countries

In short

Non-small cell lung cancer is a disease that changes lives in profound and unexpected ways, affecting not just physical health but emotional well-being, relationships, and the ability to carry out everyday activities that many take for granted.

Key points

  • Non-small cell lung cancer is the most common type of lung cancer, making up 80% to 85% of all cases, and grows more slowly than small cell lung cancer.
  • The disease is often diagnosed after it has already spread because it may not cause symptoms in the early stages, highlighting the importance of screening for high-risk individuals.
  • There are three main types—adenocarcinoma, squamous cell carcinoma, and large cell carcinoma—each with different behaviors and origins within the lung.
  • Smoking is the leading risk factor, but exposure to radon, asbestos, family history, and other environmental factors also increase risk.
  • The cancer can spread to bones, brain, liver, adrenal glands, lymph nodes, and skin, causing serious complications that affect quality of life.
  • Daily life is significantly impacted, with physical symptoms like fatigue and breathlessness limiting activities, and emotional challenges requiring mental health support.
  • Clinical trials offer access to new treatments and can provide hope, while also contributing valuable data to advance lung cancer research for future patients.
  • Family support—both practical and emotional—is essential for helping patients navigate the challenges of living with non-small cell lung cancer.

Understanding What Lies Ahead: Prognosis

When someone receives a diagnosis of non-small cell lung cancer, one of the first questions that comes to mind is what the future holds. The outlook for this disease depends heavily on when it is discovered and how far it has spread. Because non-small cell lung cancer often grows more slowly than other types of lung cancer, there is a window of opportunity for treatment, but the challenge is that many people do not experience noticeable symptoms until the cancer has already moved beyond the lungs.

The prognosis varies significantly based on the stage of the cancer, which refers to how large the tumor is and whether it has spread to lymph nodes or other organs. Early detection offers the best chance for recovery, but unfortunately, this disease is often diagnosed at a more advanced stage. Even though non-small cell lung cancer cells are larger and typically grow more slowly compared to small cell lung cancer, the lack of early symptoms means the cancer can quietly spread to other parts of the body before anyone realizes something is wrong.

Several factors influence what someone can expect. The type of non-small cell lung cancer matters—whether it is adenocarcinoma, which usually forms in the outer portions of the lung; squamous cell carcinoma, which typically starts in the central part; or large cell carcinoma, which can develop anywhere in the lungs. Each behaves differently and responds to treatments in its own way. A person's overall health, lung function, and whether they have other respiratory conditions like chronic obstructive pulmonary disease or pulmonary fibrosis also play important roles in determining outcomes.

It is important to approach these conversations with sensitivity and honesty. For many, hearing about prognosis can be overwhelming, but understanding what to expect helps in making informed decisions about treatment and planning for the future. Some people find comfort in knowing the facts, while others prefer to focus on day-to-day living. Both approaches are valid, and healthcare providers aim to support patients through whatever path feels right for them.

How the Disease Unfolds Without Treatment

If non-small cell lung cancer goes untreated, the disease will continue to progress, though the pace varies from person to person. The cancer cells, which began as normal lung cells that changed and started growing out of control, will continue to multiply and form larger tumors. Over time, these tumors can block airways, making it harder to breathe and causing persistent coughing, chest pain, and shortness of breath.

As the disease advances, the cancer does not stay confined to the lungs. It has the ability to spread, or metastasize, to other organs and tissues. The most common places for non-small cell lung cancer to spread include the bones, brain, liver, adrenal glands, lymph nodes, and skin. When cancer reaches the bones, it can cause deep pain and increase the risk of fractures. If it spreads to the brain, it may lead to headaches, confusion, weakness, or seizures. Liver involvement can cause jaundice, abdominal pain, and digestive problems.

Without intervention, symptoms become more severe and debilitating. The body's ability to get enough oxygen diminishes as lung function declines. Weight loss becomes more pronounced as the cancer consumes energy and affects appetite. Fatigue intensifies, making even simple tasks exhausting. The immune system weakens, leaving the body vulnerable to infections. Eventually, vital organs can fail as the cancer burden becomes too great for the body to sustain.

The natural progression of this disease underscores why early detection and treatment are so crucial. The sooner the cancer is identified and addressed, the better the chance of slowing its growth, managing symptoms, and improving quality of life.

Possible Complications That May Arise

Living with non-small cell lung cancer means being aware of complications that can develop as the disease progresses or as a result of treatments. These complications can range from manageable to serious, and understanding them helps patients and families prepare for what might come.

One common complication is the buildup of fluid around the lungs, a condition called pleural effusion. This happens when cancer cells irritate the thin membrane surrounding the lungs, causing fluid to accumulate. The result is increased difficulty breathing, chest discomfort, and a feeling of heaviness in the chest. Doctors can drain this fluid to provide relief, but it may return and require repeated procedures.

Cancer that spreads to the bones can cause fractures, even from minor injuries or normal daily activities. These fractures are painful and can severely limit mobility. Bone metastases also cause persistent, deep pain that can be difficult to control and may require strong pain medications or radiation therapy to manage.

When the cancer reaches the brain, complications can include neurological symptoms such as severe headaches, seizures, changes in vision, difficulty with balance and coordination, personality changes, and cognitive problems. These symptoms can be frightening for both patients and their loved ones and often require specialized care from neurologists and oncologists.

Breathing problems become more severe as the disease progresses. Tumors can block major airways, leading to a collapsed lung, repeated lung infections, or pneumonia. Chronic shortness of breath can make even sitting still feel exhausting and may require supplemental oxygen to maintain adequate oxygen levels in the blood.

The cancer itself and its treatments can weaken the immune system, making infections more likely and harder to fight off. Chemotherapy, radiation therapy, and some targeted treatments can lower white blood cell counts, leaving the body vulnerable to bacterial, viral, and fungal infections.

Blood clots are another concern. Cancer increases the risk of developing clots in the legs, known as deep vein thrombosis, which can break loose and travel to the lungs, causing a life-threatening condition called pulmonary embolism. Symptoms include sudden shortness of breath, chest pain, rapid heart rate, and coughing up blood.

The Impact on Everyday Life

Non-small cell lung cancer affects far more than just the lungs. It touches every aspect of daily living, from the physical to the emotional, social, and practical. Understanding these impacts helps patients, families, and caregivers navigate the challenges that come with the disease.

Physically, the symptoms of non-small cell lung cancer can be exhausting. Persistent coughing, shortness of breath, and chest pain make simple activities like walking up stairs, carrying groceries, or even getting dressed feel overwhelming. Fatigue is one of the most common complaints, a deep tiredness that does not improve with rest. This fatigue can be caused by the cancer itself, treatments like chemotherapy and radiation, or a combination of both.

Many people find they need to pace themselves throughout the day, breaking tasks into smaller, more manageable pieces and taking frequent breaks. Activities that once were second nature now require planning and effort. Some may need to use mobility aids like walkers or wheelchairs, or rely on supplemental oxygen to help with breathing.

Emotionally, a lung cancer diagnosis can feel like the ground has shifted beneath your feet. Fear, anxiety, sadness, and anger are all normal responses. The uncertainty of not knowing what the future holds, the stress of medical appointments and treatments, and the fear of leaving loved ones behind can be overwhelming. Some people experience depression, which is more than just feeling sad—it is a persistent sense of hopelessness that interferes with daily functioning. It is important to recognize these feelings and seek support from mental health professionals, counselors, or support groups.

Social life often changes as well. Energy levels may not allow for the same level of social activity as before. Some people withdraw because they feel self-conscious about their symptoms, such as coughing or needing oxygen, or because they do not want to burden others with their problems. Others find that their social circles shift, as some friends may not know how to respond to the diagnosis and may pull away, while new connections form with fellow patients and survivors who truly understand the experience.

Work can become complicated. Depending on the severity of symptoms and side effects from treatment, some people can continue working with modifications, such as reduced hours, flexible schedules, or the ability to work from home. Others may need to take extended leave or retire earlier than planned. The financial impact of losing income, combined with medical expenses, can add significant stress to an already difficult situation.

Hobbies and activities that once brought joy may need to be adapted or set aside. Gardening, playing sports, traveling, or even reading for long periods may become difficult when fatigue and breathing problems dominate. Finding new ways to stay engaged and maintain a sense of purpose is important for emotional well-being.

Coping strategies vary, but some approaches can help. Staying as physically active as possible, within the limits set by symptoms and treatments, can improve energy levels and mood. Gentle exercises like walking, stretching, or yoga may be beneficial. Eating a balanced diet, even when appetite is poor, helps maintain strength. Many people find comfort in mindfulness practices, meditation, or prayer. Staying connected with loved ones, whether through phone calls, video chats, or in-person visits, provides emotional support and reduces feelings of isolation.

Practical support is also crucial. Family members and friends can help with daily tasks like cooking, cleaning, shopping, and transportation to medical appointments. Accepting help can be difficult, but it is important to let others in and allow them to support you during this time.

Supporting Family Members Through Clinical Trials

Clinical trials are research studies that test new treatments, diagnostic tools, or ways to manage symptoms. They play a vital role in advancing cancer care and can offer patients access to cutting-edge therapies that are not yet widely available. For families of people with non-small cell lung cancer, understanding clinical trials and knowing how to support a loved one who is considering or participating in one is important.

Clinical trials for non-small cell lung cancer may test new chemotherapy drugs, targeted therapies, immunotherapies, radiation techniques, or combinations of treatments. Some trials focus on improving quality of life by managing symptoms or side effects. Others explore better ways to diagnose the disease or predict how it will respond to treatment.

One of the most important things families can do is help their loved one understand what participation involves. Clinical trials are voluntary, and patients have the right to ask questions, take time to consider their options, and withdraw at any time if they choose. Families can support this decision-making process by attending medical appointments, taking notes, and helping research the trial to understand its purpose, potential benefits, and possible risks.

Finding clinical trials can feel overwhelming, but there are resources to help. The National Cancer Institute, cancer centers, and advocacy organizations provide databases where families can search for trials based on the type and stage of cancer, location, and other factors. Healthcare providers can also recommend trials that might be a good fit.

Practical support is crucial for someone participating in a clinical trial. Trials often require frequent visits to the medical center for tests, treatments, and monitoring. Family members can help by providing transportation, attending appointments, keeping track of schedules, and managing paperwork. Emotional support is equally important. Participating in a trial can bring hope but also anxiety about the unknown. Being there to listen, offer reassurance, and provide a sense of normalcy helps immensely.

Families should also be aware that not everyone is eligible for every trial. Trials have specific criteria, such as the stage of cancer, previous treatments, overall health, and other medical conditions. If a loved one is not eligible for one trial, there may be others to consider. It is important to remain open to different options and to have ongoing conversations with the medical team about what is available.

Understanding that clinical trials contribute to the greater good can provide comfort. Even if a particular treatment does not work for one person, the data collected helps researchers learn more about the disease and develop better treatments for future patients. Many families find meaning in knowing their loved one is contributing to progress in the fight against lung cancer.

Registered drugs used for this disease

The sources provided do not specify particular registered drugs by name for non-small cell lung cancer. Treatment options mentioned include surgery, chemotherapy, radiation therapy, targeted therapy, and immunotherapy, but individual drug names were not detailed in the provided information.

Did you know?

  1. Non-small cell lung cancer accounts for about 80% to 85% of all lung cancer cases, making it by far the most common type of lung cancer diagnosed worldwide.
  2. The cancer is named not for its size, but for how the cells appear under a microscope—they are larger compared to the small, round cells seen in small cell lung cancer.
  3. While smoking is the leading risk factor, approximately 10% to 15% of people diagnosed with non-small cell lung cancer have never smoked, showing that anyone can be affected.

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Clinical trials for Non-small cell lung cancer

Recruiting trials first

See all 326 trials →
Quick filters

326 clinical trials in this condition

Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:HLX43
  • Sponsor:Shanghai Henlius Biotech Inc.
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:AstraZeneca AB
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:BNT327
  • Sponsor:BioNTech SE
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:AstraZeneca AB
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Divarasib
  • Sponsor:F. Hoffmann-La Roche AG
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Amivantamab
  • Sponsor:Janssen - Cilag International
See all 326 trials →filters applied: condition = Non-small cell lung cancer

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).